Listed

Seneca Foods Corp: Form 10-Q for the period ended Jul 2, 2022

Filed with the SEC on Aug 11, 2022 and accepted by EDGAR at Aug 11, 2022, 20:13 ET.

Share

Management's discussion and analysis

As filed, 850 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Period Total Number of Shares Purchased Class A Common Class B Common Average Price Paid per Share Class A Common Class B Common Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs
4/01/2022 – 4/30/2022 81,480 - $54.26 - 81,480
05/01/2022 – 05/31/2022 (1) 81,135 - $54.52 - 70,018
06/1/2022 06/30/2022 124,384 - $53.69 - 124,384
Total 286,999 - $54.19 - 275,882 506,399

(1) Includes 11,117 shares that were purchased in open market transactions by the trustees under the Seneca Foods Corporation Employees' Savings Plan to provide employee matching contributions under the plan.

Market risk

As filed, 551 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In the ordinary course of business, the Company is exposed to various market risk factors, including changes in general economic conditions, competition and raw material pricing and availability. In addition, the Company is exposed to fluctuations in interest rates, primarily related to its revolving credit facility. To manage interest rate risk, the Company uses both fixed and variable interest rate debt plus fixed interest rate lease obligations. There have been no material changes to the Company’s exposure to market risk since March 31, 2022.

Controls and procedures

As filed, 1,463 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company maintains a system of internal and disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed or submitted under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported on a timely basis. The Company’s Board of Directors, operating through its Audit Committee, which is composed entirely of independent outside directors, provides oversight to the financial reporting process.

An evaluation was performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities and Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that, as of July 2, 2022, our disclosure controls and procedures were effective. The Company continues to examine, refine and formalize its disclosure controls and procedures and to monitor ongoing developments in this area.

There have been no changes during the period covered by this report to the Company's internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

Risk factors

As filed, 251 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes to the risk factors disclosed in the Company’s Annual Report Form 10-K for the period ended March 31, 2022 except to the extent factual information disclosed elsewhere in this Form 10-Q relates to such risk factors.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-07-02. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-04-01 to 2022-07-02$265.2mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Cost of revenue3 months2022-04-01 to 2022-07-02$242.3mus-gaap:CostOfGoodsAndServicesSold
Selling, general and administrative3 months2022-04-01 to 2022-07-02$18.2mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-04-01 to 2022-07-02$6.6mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-04-01 to 2022-07-02$1.4mus-gaap:InterestExpense
Income tax3 months2022-04-01 to 2022-07-02$1.6mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-04-01 to 2022-07-02$5.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-04-01 to 2022-07-02$0.62us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-04-01 to 2022-07-02$0.62us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-04-01 to 2022-07-028,227 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2022-04-01 to 2022-07-02−$22.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2022-04-01 to 2022-07-02$19.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2022-04-01 to 2022-07-02$12.0kus-gaap:PaymentsOfDividends
Share repurchases3 months2022-04-01 to 2022-07-02$15.9mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2022-07-02$12.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-07-02$633.9mus-gaap:AssetsCurrent
Total assetsAt period end2022-07-02$1.03bnus-gaap:Assets
Current liabilitiesAt period end2022-07-02$216.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-07-02$459.1mus-gaap:Liabilities
Long-term debtAt period end2022-07-02$167.1mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2022-07-02$4.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2022-07-02$573.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-22-020128. Last ingested by Listed: Oct 24, 2026, 14:54 ET. Listed shows no prices and gives no investment advice.